NCT05424263View on ClinicalTrials.gov

Acetate and Age-associated Arterial Dysfunction

PHASE2RecruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

September 29, 2022

Primary Completion Date

July 1, 2025

Study Completion Date

September 1, 2025

Conditions
AgingVascular StiffnessVascular Dilation
Interventions
DRUG

Calcium Acetate Oral Solution

Subjects will be supplemented with calcium acetate (4,000 mg/day), as described in the arm/group descriptions, for 12 weeks.

DRUG

Calcium Carbonate Oral Suspension

Subjects will be supplemented with calcium carbonate (2,500 mg/day), as described in the arm/group descriptions, for 12 weeks.

Trial Locations (1)

80045

RECRUITING

University of Colorado Anschutz Medical Campus, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER